ask="4.80"
ask_size="300"
average_daily_volume="421310"
bid="3.70"
bid_size="2000"
book_value="3.74"
change="-0.06"
change_from_200_day_moving_average="1.88"
change_from_50_day_moving_average="-0.17"
change_from_52_week_high="-2.46"
change_From_52_week_low="3.44"
change_in_percent="-1.39%"
close="4.26"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="18915000"
high="4.49"
high_52_weeks="6.72"
last_trade_date="2/3/2017"
last_trade_price="4.26"
last_trade_size="250274"
last_trade_time="4:00pm"
low="4.26"
low_52_weeks="0.82"
market_capitalization="96.07M"
moving_average_200_day="2.38"
moving_average_50_day="4.43"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.36"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+78.84%"
percent_change_from_50_day_moving_average="-3.84%"
percent_change_from_52_week_high="-36.61%"
percent_change_from_52_week_low="+419.51%"
previous_close="4.32"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.16"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="6.55"
stock_exchange="NMS"
symbol="CASC"
volume="646286"
weeks_range_52="0.82 - 6.72"
